Welcome to our dedicated page for Terrascent SEC filings (Ticker: TSNDF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TerrAscend Corp. filings document the regulatory record of a Canadian cannabis operator whose common shares trade on OTCQX under TSNDF. Its Form 8-K reports furnish quarterly and annual operating results, preliminary results, business highlights, and continuing-operations measures for the company’s retail, wholesale, cultivation, processing, and manufacturing activities.
Other filings cover governance and capital-structure matters, including definitive proxy materials for annual shareholder votes, director elections, auditor ratification, executive officer appointments and compensation arrangements, and unregistered securities disclosures involving convertible promissory notes. The filing record also reflects material agreements, risk-factor context, and disclosures tied to TerrAscend’s cannabis operations and discontinued Michigan operations.
TerrAscend Corp. reported first quarter 2026 net revenue of $65.5 million, up slightly from $64.3 million a year earlier, with a gross profit margin of 52.8%. The company posted a GAAP net loss from continuing operations of $6.8 million, similar to the prior-year loss.
Profitability on a cash and adjusted basis was stronger: Adjusted EBITDA from continuing operations was $17.4 million, a 26.5% margin, while free cash flow was $7.8 million, marking the 11th consecutive quarter of positive free cash flow and 15th of positive operating cash flow. TerrAscend ended the quarter with $39.1 million in cash and cash equivalents and continued to gain retail share in key states such as New Jersey, Maryland, and Pennsylvania. Management highlighted the U.S. Department of Justice’s rescheduling of certain medical cannabis to Schedule III, which they believe removes the 280E tax burden on medical cannabis and could, over time, support better profitability, balance sheet strength, and potential access to major U.S. exchanges.
TerrAscend Corp. granted its Chief Financial Officer, Eric Matthew Jackson, stock options covering 300,000 common shares. The options have an exercise price of $0.76 per share and expire on April 27, 2036. They vest in four equal annual installments beginning on the first anniversary of the grant date, aligning compensation with longer-term company performance.
TerrAscend Corp. filed an initial insider ownership report for Eric Matthew Jackson, who serves as Chief Financial Officer. This Form 3 filing establishes his status as a reporting insider. The provided data show no reported buy, sell, or other share transactions in this filing.
TerrAscend Corp. reported preliminary, unaudited first-quarter 2026 results from continuing operations, excluding Michigan, which is treated as discontinued. The Company expects net revenue of $65.5 million, slightly above the first quarter of 2025 but modestly below the fourth quarter of 2025. Gross profit margin is anticipated at 52.8%, essentially in line with recent periods. General and administrative expenses were flat quarter-over-quarter, and TerrAscend generated positive cash flow from operations for the 15th consecutive quarter, highlighting ongoing cash generation.
Management cited year-over-year revenue growth from continuing operations and profitability metrics exceeding internal targets. TerrAscend also referenced recent U.S. federal rescheduling of certain medical cannabis to Schedule III and an upcoming hearing on broader rescheduling, noting that federal law and enforcement remain a significant risk. The Company plans to discuss detailed first-quarter 2026 results on an earnings conference call on May 7, 2026 at 8:00 a.m. Eastern Time.
TerrAscend Corp. has called a fully virtual annual meeting for June 9, 2026 at 1:00 p.m. Eastern Time to let shareholders vote on key governance and compensation matters. Holders of common shares as of April 13, 2026 can vote one share per vote.
Shareholders will elect five directors, ratify MNP LLP as auditor for 2026, and vote on renewing all unallocated awards under TerrAscend’s rolling Stock Option Plan and Share Unit Plan, which together may cover up to 15% of outstanding shares. The circular also highlights U.S. federal legal risks to its cannabis operations and outlines detailed proxy, broker, and virtual participation procedures.
TerrAscend Corp. appointed Eric Jackson as Chief Financial Officer, effective April 27, 2026. Jackson has more than two decades of finance and operational leadership experience, including senior roles at American Signature and L Brands supporting large, multi-location retail businesses.
Under his employment agreement, Jackson will receive a $450,000 annual base salary, a target annual bonus equal to 60% of salary (with the 2026 bonus guaranteed on a pro rata basis), and annual restricted stock units valued at up to 75% of salary. He will also receive options to purchase 300,000 common shares, vesting in four equal annual installments and carrying a ten-year term.
If his employment is terminated without cause or he resigns for good reason, Jackson is entitled to 12 months of salary as severance, a cash amount equal to 12 months of the company’s share of his medical coverage, specified bonus payments, and pro rata vesting of unvested options and RSUs. In a qualifying termination within 24 months after a change of control, cash severance and medical stipends increase to two times these amounts and all unvested equity vests. Post-employment, he is subject to non-solicitation and non-competition covenants for 12 months.
TerrAscend Corp. Chief People and Legal Officer Lynn K. Gefen reported routine share withholdings to cover taxes on equity compensation. On two dates, a total of 13,003 Common Shares were withheld by the company to satisfy tax obligations tied to restricted share unit settlement under its equity plan. After these tax-withholding dispositions, Gefen directly holds 1,081,715 Common Shares.
TerrAscend Corp. reported an insider transaction by President and CEO Ziad Ghanem involving share withholdings for tax purposes rather than market sales. On two dates, the company withheld common shares to cover tax obligations tied to restricted share unit settlements under its equity plan.
The issuer withheld 22,017 common shares at $0.66 per share and 9,998 common shares at $0.62 per share, totaling 32,015 shares. After these tax-withholding dispositions, Ghanem directly owned 2,864,884 common shares of TerrAscend.